The impact of new emerging drugs in the treatment of multiple myeloma: Is there still a role for PBSC transplantation?

Research output: Contribution to journalArticlepeer-review

Abstract

High-dose therapy with the rescue of autologous stem cells represents today the standard approach for multiple myeloma patients aged

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalCurrent Stem Cell Research and Therapy
Volume2
Issue number1
Publication statusPublished - Jan 2007

Keywords

  • Bortezomib
  • Chemotherapy
  • Lenalidomide
  • Thalidomide
  • Transplantation

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Fingerprint Dive into the research topics of 'The impact of new emerging drugs in the treatment of multiple myeloma: Is there still a role for PBSC transplantation?'. Together they form a unique fingerprint.

Cite this